Berobenatide
VESPER-1
Pfizer · Phase 2 · Completed · Enrollment 239
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| MET097 Active | Obesity or overweight | n/r | 28 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 28 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Berobenatide
Pfizer · Phase 2 · Completed · Enrollment 239
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| MET097 Active | Obesity or overweight | n/r | 28 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 28 | n/r | n/r |